Penny Johnson

410 total citations
9 papers, 349 citations indexed

About

Penny Johnson is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Penny Johnson has authored 9 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Penny Johnson's work include Lung Cancer Treatments and Mutations (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). Penny Johnson is often cited by papers focused on Lung Cancer Treatments and Mutations (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). Penny Johnson collaborates with scholars based in United Kingdom, United States and Netherlands. Penny Johnson's co-authors include Ian A. Cree, Federica Di Nicolantonio, Sharon Glaysher, Louise A. Knight, Pauline A. Whitehouse, Stuart Mercer, Sanjay Sharma, Jeremy Hurren, D. Timothy Bishop and Robert M. Fineman and has published in prestigious journals such as The Journal of Pathology, Vaccine and BMC Cancer.

In The Last Decade

Penny Johnson

9 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Penny Johnson United Kingdom	9	148	145	77	69	48	9	349
Pauline A. Whitehouse United Kingdom	9	193 1.3×	140 1.0×	89 1.2×	50 0.7×	27 0.6×	12	345
Michèle Harrison Ireland	8	162 1.1×	211 1.5×	64 0.8×	125 1.8×	47 1.0×	9	444
Birte Andritzky Germany	8	152 1.0×	187 1.3×	91 1.2×	67 1.0×	42 0.9×	13	350
L. Moretti Belgium	9	144 1.0×	148 1.0×	54 0.7×	38 0.6×	57 1.2×	23	457
Mustafa A. Barbhuiya India	11	106 0.7×	244 1.7×	67 0.9×	76 1.1×	46 1.0×	19	424
Christoph Wilmanns Australia	5	150 1.0×	116 0.8×	31 0.4×	67 1.0×	32 0.7×	6	320
Manu Prasad Israel	12	146 1.0×	183 1.3×	59 0.8×	83 1.2×	54 1.1×	27	359
Marlene R.D. Quadros United States	7	189 1.3×	201 1.4×	57 0.7×	60 0.9×	42 0.9×	8	370
Yan C. Wang United States	6	173 1.2×	234 1.6×	48 0.6×	123 1.8×	84 1.8×	9	394
Aušra Sasnauskienė Lithuania	10	87 0.6×	198 1.4×	76 1.0×	91 1.3×	49 1.0×	23	366

Countries citing papers authored by Penny Johnson

Since Specialization

Citations

This map shows the geographic impact of Penny Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Penny Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Penny Johnson more than expected).

Fields of papers citing papers by Penny Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Penny Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Penny Johnson. The network helps show where Penny Johnson may publish in the future.

Co-authorship network of co-authors of Penny Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Penny Johnson. A scholar is included among the top collaborators of Penny Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Penny Johnson. Penny Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Glaysher, Sharon, et al.. (2014). Activity of EGFR, mTOR and PI3K inhibitors in an isogenic breast cell line model. BMC Research Notes. 7(1). 397–397. 15 indexed citations

Glaysher, Sharon, Dennis Yiannakis, Francis G Gabriel, et al.. (2009). Resistance gene expression determines the in vitro chemosensitivity of non-small cell lung cancer (NSCLC). BMC Cancer. 9(1). 300–300. 33 indexed citations

Bhandari, Pradeep, Adrian C Bateman, Raj Mehta, et al.. (2006). Prognostic significance of cyclooxygenase-2 (COX-2) expression in patients with surgically resectable adenocarcinoma of the oesophagus. BMC Cancer. 6(1). 134–134. 31 indexed citations

Polak, Marta E., Penny Johnson, Silvana Di Palma, et al.. (2005). Presence and maturity of dendritic cells in melanoma lymph node metastases. The Journal of Pathology. 207(1). 83–90. 18 indexed citations

Nicolantonio, Federica Di, Stuart Mercer, Louise A. Knight, et al.. (2005). Cancer cell adaptation to chemotherapy. BMC Cancer. 5(1). 78–78. 112 indexed citations

Knight, Louise A., Federica Di Nicolantonio, Pauline A. Whitehouse, et al.. (2004). The in vitroeffect of gefitinib ('Iressa') alone and in combination with cytotoxic chemotherapy on human solid tumours. BMC Cancer. 4(1). 83–83. 54 indexed citations

Nicolantonio, Federica Di, Louise A. Knight, Sharon Glaysher, et al.. (2004). Ex vivo reversal of chemoresistance by tariquidar (XR9576). Anti-Cancer Drugs. 15(9). 861–869. 20 indexed citations

Lees, Andrew, et al.. (1994). Enhanced immunogenicity of protein-dextran conjugates: I. Rapid stimulation of enhanced antibody responses to poorly immunogenic molecules. Vaccine. 12(13). 1160–1166. 25 indexed citations

Livingston, Gordon K., Lisa A. Cannon, D. Timothy Bishop, Penny Johnson, & Robert M. Fineman. (1983). Sister chromatid exchange: Variation by age, sex, smoking, and breast cancer status. Cancer Genetics and Cytogenetics. 9(3). 289–299. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact